What is Tiziana Life Sciences Ltd (TLSA) stock price today?

Tiziana Life Sciences Ltd (TLSA) currently trades at $1.28 per share. The stock has a market capitalization of $159.06M and a P/E ratio of —x.

Is TLSA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Tiziana Life Sciences Ltd has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Tiziana Life Sciences Ltd's revenue and earnings?

Tiziana Life Sciences Ltd has trailing twelve-month (TTM) revenue of $-3.60M with profit margins of 0.00%. Earnings per share (EPS) is $-0.12.

TLSA

Tiziana Life Sciences Ltd

NASDAQ: TLSA · HEALTHCARE · BIOTECHNOLOGY

$1.28

+1.59% today

Updated 2026-04-30

Market cap

$159.06M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.12

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

Market cap

$159.06M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.12

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$8.02

+526.56%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-6.83M

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$-3.60M
Net income	$-23.42M	$-15.40M	$-17.69M	$-11.86M	$-5.63M
EPS	—	—	—	—	$-0.12
Free cash flow	$-16.15M	$-15.99M	$-12.42M	$-1.23M	$-6.83M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TLSA	$159.06M	16	4.3	3.0	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Tiziana Life Sciences Ltd trades at $1.28. Our Smart Value Score of 16/100 indicates the stock is weak. TTM revenue stands at $-3.60M.

Frequently asked questions

What is Tiziana Life Sciences Ltd's stock price?

Tiziana Life Sciences Ltd (TLSA) trades at $1.28.

Is Tiziana Life Sciences Ltd overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Tiziana Life Sciences Ltd (TLSA)?

The analyst target price is $8.02, representing +526.6% upside from the current price of $1.28.

What is Tiziana Life Sciences Ltd's revenue?

TTM revenue is $-3.60M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-232.30%

Beta0.37

50D MA$1.30

200D MA$1.66

Shares out0.13B

Float0.06B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TLSA vs LLY →TLSA vs JNJ →TLSA vs ABBV →Stock screener →